Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina...
64 insider purchases on record · latest filing 2026-03-25.
Insiders have also filed 8 sale transactions at SRZN.